Rehabilitation and COVID-19: update of the rapid living systematic review by Cochrane Rehabilitation Field as of February 28th, 2022

Abstract

rehabilitation and coVid-19: update of the rapid living systematic review by cochrane rehabilitation field as of february 28 th , 2022The present update follows the methodology defined in the 3 rd edition of the rapid living systematic review (rlsr) conducted as part of the cochrane rehabilitation rEh-coVEr (rehabilitation coVid-19 Evidence-based response) action. 1 table i lists the main characteristics of this update. 1 We identified 7407 studies from the databases.After removing duplicates and title and abstract screening, we evaluated 105 studies of which we included 38 in the qualitative synthesis.tables ii 2-40 and iii 41 present the distribution of selected studies stratified by limitations of functioning of rehabilitation interest (lfri), disease phase and rehabilitation setting (table ii), research question, and study design (table iii).figures in table ii and iii are displayed in face of the cumulative data from all papers included in the rlsr 3 rd edition (and published from May 1 st , 2021 through february 28 th , 2022).The main findings from the current bi-monthly update concern:• the relevance of dysphagia in coVid-19 patients admitted to the intensive care units (icus).two prospective cohort studies, totaling 55 cases, focused attention on two comparable cohorts of adults (mean age: 61 17 vs.65 years; 16 males: 79% 17 vs.81.5% 16 ) in order to evaluate the dose-effectiveness of the treatment.in addition, because of the typically bilateral involvement of ul in Ms, future studies should explore the possibility to implement an alternating ciMt protocol in order to increase ul functionality of both arms.We recommend the need for future studies to define standardized dose-effective CIMT protocols with a clearly defined number and length of sessions, frequency and percentage of constraint that could be feasible for both inpatient and outpatient settings.